skip to content

Institute of Metabolic Science

Metabolic Research Laboratories
 

I am a Wellcome Clinical Career Development Fellow and Honorary Consultant in Endocrinology & Diabetes. My research uses advanced genomic and molecular techniques to

  1. uncover novel mechanisms of hormone secretion and action across endocrine systems and
  2. understand how these processes are disrupted in human disease, with a particular focus on the reproductive consequences of obesity and insulin resistance.

Background

I combined medical training with doctoral research via the University of Cambridge MB/PhD programme. During my PhD at the IMS-MRL (working with Professor Robert Semple), I investigated novel monogenic syndromes of severe insulin resistance. After foundation clinical training in London, I returned to the IMS-MRL as an NIHR Academic Clinical Fellow before joining Professor Sadaf Farooqi’s group as an NIHR Clinical Lecturer in Endocrinology and Diabetes.

Current Projects

With Professor Farooqi, and in collaboration with Professor Sarah Teichmann (Cambridge Stem Cell Institute), my current research uses single cell genomics to profile patterns of hormone production and action across human tissues.  This work is allowing us to discover and investigate the function of novel mediators of hormone action in different cellular contexts.. 

Publications

Key publications: 

Mericq V, Huang-Doran I, Al-Naqeb D, Basaure J, Castiglioni C, de Bruin C, Hendriks Y, Bertini E, Alkuraya FS, Losekoot M, Al-Rubeaan K, Semple RK, Wit JM. Biallelic POC1A variants cause syndromic severe insulin resistance with muscle cramps. Eur J Endocrinol. 2022 Mar 23;186(5):543-552. doi: 10.1530/EJE-21-0609

Huang-Doran I, Kinzer AB, Jimenez-Linan M, Thackray K, Harris J, Adams CL, de Kerdanet M, Stears A, O'Rahilly S, Savage DB, et al. Ovarian hyperandrogenism and its response to gonadotropin-releasing hormone analogue therapy in primary severe insulin resistance. J Clin Endocrinol Metab. 2021 Jul 13;106(8):2367-2383. DOI: 10.1210/clinem/dgab275

Lawler K*, Huang-Doran I*, Sonoyama T, Collet TH, Keogh JM, Henning E, O'Rahilly S, Bottolo L, Farooqi IS. Leptin-mediated changes in the human metabolome. J Clin Endocrinol Metab. 2020 Aug 1;105(8):2541–52.https://doi.org/10.1210/clinem/dgaa251

Kwok A, Zvetkova I, Virtue S, Luijten I, Huang-Doran I, Tomlinson P, Bulger DA, West J, Murfitt S, Griffin J, et al. Truncation of Pik3r1 causes severe insulin resistance uncoupled from obesity and dyslipidaemia by increased energy expenditure. Mol Metab. 2020 Oct;40:101020. DOI: 10.1016/j.molmet.2020.101020

Huang-Doran I, Tomlinson P, Payne F, Gast A, Sleigh A, Bottomley W, Harris J, Daly A, Rocha N, Rudge S, et al. Insulin resistance uncoupled from dyslipidemia due to C-terminal PIK3R1 mutations. JCI Insight 2016;1(17):e88766. doi: 10.1172/jci.insight.88766

Huang-Doran I, Bicknell LS, Finucane FM, Rocha N, Porter KM, Tung YC, Szekeres F, Krook A, Nolan JJ, O'Driscoll M, et al. Genetic defects in human pericentrin are associated with severe insulin resistance and diabetes. Diabetes 2011;60(3):925-35. DOI: 10.2337/db10-1334

Clinical Career Development Fellow
photo of isabel huang doran

Contact Details

Email address: 
Collaborator profiles: 
Classifications: